THE ROLE OF ANTI TNF ALPHA AGENTS IN BEHCET'S DISEASE REFRACTORY TO STANDARD OF CARE THERAPIES: MULTICENTER RANDOMIZED CONTROLLED PROSPECTIVE PARALLEL GROUP SINGLE-BLIND TRIAL TO EVALUATE THE 6 MONTH EFFECTIVENESS OF EITHER INFLIXIMAB OR ADALIMUMAB
Latest Information Update: 25 Aug 2021
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Methylprednisolone (Primary) ; Methylprednisolone (Primary)
- Indications Behcet's syndrome
- Focus Therapeutic Use
- Acronyms FARM12LTAT
- 25 Aug 2021 New trial record